What is Phreesia Inc (PHR) stock price today?

Phreesia Inc (PHR) currently trades at $9.57 per share. The stock has a market capitalization of $581.50M and a P/E ratio of 239.25x.

Is PHR stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Phreesia Inc has a Smart Value Score of 43/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Phreesia Inc's revenue and earnings?

Phreesia Inc has trailing twelve-month (TTM) revenue of $480.59M with profit margins of 0.48%. Earnings per share (EPS) is $0.04.

Is PHR stock overvalued or undervalued?

Based on our DCF model, Phreesia Inc's intrinsic value is $56.21, representing a margin of safety of 77.76%. The stock currently trades at a P/E of 239.25x.

PHR

Phreesia Inc

NYSE: PHR · HEALTHCARE · HEALTH INFORMATION SERVICES

$9.57

-5.90% today

Updated 2026-05-11

Market cap

$581.50M

P/E ratio

239.25

P/S ratio

1.21x

EPS (TTM)

$0.04

Dividend yield

—

52W range

$8 – $33

Volume

2.0M

Market cap

$581.50M

P/E ratio

239.25

P/S ratio

1.21x

EPS (TTM)

$0.04

Dividend yield

—

52W range

$8 – $33

Volume

2.0M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

6.7

Growth

5.0

Quality

C+

4.0

Profitability

5.7

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$16.17

+68.97%

12-Month target

—

Intrinsic (DCF)

$56.21

Margin of safety

+77.76%

6 Strong Buy10 Buy4 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Free cash flow $31.10M — positive

+ Revenue growth 15.90% QoQ

+ 77.76% below intrinsic value

Risks

- Thin margins at 0.48%

- P/E 239.25x — expensive valuation

Key financials

Revenue Net Income Free Cash Flow

Metric	2023	2024	2025	2026	TTM
Revenue	$280.91M	$356.30M	$419.81M	$480.59M	$480.59M
Net income	$-176.15M	$-136.88M	$-58.53M	$2.31M	$1.29M
EPS	—	—	—	—	$0.04
Free cash flow	$-116.33M	$-57.48M	$8.29M	$67.71M	$31.10M
Profit margin	-62.71%	-38.42%	-13.94%	0.48%	0.48%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-04-20	HOFFMAN, ALLISON C	Sale	6,176	$9.06
2026-04-17	HUI, YVONNE	Sale	1,327	$9.28
2026-04-16	LINETSKY, DAVID	Sale	229	$9.17

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PHR	$581.50M	43	6.7	4.0	5.7	5.0	+77.76%	Hold
LLY	$869.41B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$535.63B	59	4.7	9.0	3.3	6.0	-37.47%	Buy
ABBV	$358.55B	63	4.0	8.0	4.0	5.0	-19.74%	Buy
UNH	$335.78B	54	5.3	5.5	7.3	4.8	+40.60%	Buy
AZN	$283.47B	62	6.0	8.5	5.3	5.0	+6.51%	Buy

Smart narrative

Phreesia Inc trades at $9.57. representing a P/E of 239.25x trailing earnings. Our Smart Value Score of 43/100 indicates the stock is fair. TTM revenue stands at $480.59M. with profit margins at 0.48%. Our DCF model estimates intrinsic value at $56.21.

Frequently asked questions

What is Phreesia Inc's stock price?

Phreesia Inc (PHR) trades at $9.57.

Is Phreesia Inc overvalued?

Smart Value Score 43/100 (Grade D, Sell). DCF value $56.21.

What is the price target of Phreesia Inc (PHR)?

The analyst target price is $16.17, representing +69.0% upside from the current price of $9.57.

What is the intrinsic value of Phreesia Inc (PHR)?

Based on our DCF model, intrinsic value is $56.21, a +77.8% margin of safety versus $9.57.

What is Phreesia Inc's revenue?

TTM revenue is $480.59M.

Company info

SectorHEALTHCARE

IndustryHEALTH INFORMATION SERVICES

CountryUSA

ExchangeNYSE

CurrencyUSD

Quick metrics

P/S ratio1.21x

ROE0.77%

Beta0.89

50D MA$10.18

200D MA$18.28

Shares out0.06B

Float0.05B

Short ratio—

Avg volume2.0M

Performance

1 week-0.83%

1 month+18.73%

3 months-22.88%

YTD-43.44%

1 year—

3 years—

5 years—

Compare

PHR vs LLY →PHR vs JNJ →PHR vs ABBV →Stock screener →